Keyphrases
Acute Kidney Injury
34%
All-cause Mortality
15%
Anemia of Chronic Kidney Disease
16%
Antibody Response
15%
Bacterial Infection
15%
BNT162b2
14%
BNT162b2 Vaccine
22%
Cardiovascular Morbidity
25%
Cardiovascular Mortality
22%
Chronic Kidney Disease
37%
Chronic Kidney Disease Patients
13%
Confidence Interval
35%
COVID-19
16%
Dialysis
24%
Dialysis Patients
21%
DNA Repair
22%
Estimated Glomerular Filtration Rate
22%
Etiology
14%
First Year
14%
Glomerular Hyperfiltration
22%
Graft Loss
31%
Graft Survival
46%
Hazard Ratio
17%
Hemodialysis
36%
Hemodialysis Patients
49%
Hemoglobin
15%
Humoral Response
24%
Immunosuppression
22%
Immunosuppression Reduction
17%
Increased Mortality
14%
Intravenous Iron
14%
Kidney Transplant
22%
Kidney Transplant Recipients
100%
Kidney Transplantation
91%
Major Adverse Cardiovascular Events
13%
Meta-analysis
23%
Multivariate Analysis
23%
Obesity
24%
Odds Ratio
16%
Patient Survival
15%
Peripheral Blood Mononuclear Cells
17%
Pretransplant
15%
Randomized Controlled Trial
17%
Retrospective Cohort Study
25%
SIADH
23%
Single Center
21%
Systematic Meta-analysis
33%
Third Dose
15%
Transplantation
25%
Vaccine Dose
14%
Medicine and Dentistry
Acute Kidney Injury
35%
All Cause Mortality
10%
Anemia
21%
Angiotensin Receptor Antagonist
7%
Antibody Response
9%
Bacterial Infection
15%
Bloodstream Infection
11%
Calcineurin Inhibitor
9%
Cancer
12%
Cardiovascular Disease
14%
Cardiovascular System
24%
Chronic Kidney Disease
44%
Cohort Analysis
13%
COVID-19 Vaccine
11%
Diabetes
13%
Diabetes Mellitus
10%
DNA Repair
16%
End Stage Renal Disease
8%
Glomerular Filtration Rate
24%
Graft Failure
31%
Graft Survival
22%
Hazard Ratio
14%
Hemodialysis
49%
Humoral Immunity
11%
Immunosuppressive Drug
8%
Immunosuppressive Treatment
28%
Inappropriate Vasopressin Secretion
12%
Infection
27%
Iron
24%
Kidney Function
24%
Kidney Graft
86%
Kidney Transplantation
76%
Living Donors
8%
Meta-Analysis
22%
Multivariate Analysis
16%
Nephropathy
13%
Odds Ratio
10%
Percutaneous Aortic Valve Replacement
11%
Peripheral Blood Mononuclear Cell
12%
Prevalence
8%
Proportional Hazards Model
8%
Randomized Controlled Trial
23%
Retransplantation
9%
Retrospective Cohort Study
24%
Retrospective Study
21%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Supplementation
23%
Systematic Review
22%
Ultrafiltration
22%
Univariate Analysis
8%